Pharmacogenetics of Cannabinoid Response

Conditions

COMT Gene Polymorphism

What is the purpose of this trial?

This study attempts to examine genetic influences on the effects of tetrahydrocannabinol (Δ9-THC), the active ingredient of marijuana, cannabis, "ganja", or "pot".



Participation Guidelines

Age:
18 Years - 55 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute on Drug Abuse (NIDA)
Yale University
Dates:
July 2007
Last Updated:
April 1, 2014
Study HIC#:
0706002754

Clinicaltrials.gov ID: NCT00678730